Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.

Abstract

OBJECTIVES To prospectively investigate the associations of baseline serum anti-phospholipid antibody (APLA) status on evolution of clinical and MRI measures in a multiple sclerosis (MS) patient cohort treated with interferon-beta (IFN-beta). METHODS Forty-seven relapsing-remitting (RR) MS patients, [26 APLA-positive (APLA(+)) and 21 APLA-negative (APLA… (More)
DOI: 10.1179/1743132812Y.0000000076

Topics

Cite this paper

@article{Zivadinov2012AntiphospholipidAA, title={Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.}, author={Robert Zivadinov and Murali Ramanathan and Julian L Ambrus and Sara Hussein and Deepa Ramasamy and Michael G. Dwyer and Niels P Bergsland and Alireza Minagar and Bianca Weinstock-Guttman}, journal={Neurological research}, year={2012}, volume={34 8}, pages={761-9} }